DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy by Olaussen Ken A, Dunant Ariane, Fouret Pierre, Brambilla Elisabeth, André Fabrice, Haddad Vincent, Taranchon Estelle, Filipits Martin, Pirker Robert, Popper Helmut H, Stahel Rolf, Sabatier Laure, Pignon Jean-Pierre, Tursz Thomas, Le Chevalier Thierry, Soria Jean-Charles, IALT Bio Investigators in The New England journal of medicine (2006).

[PMID: 16957145] PubMed


Adjuvant cisplatin-based chemotherapy improves survival among patients with completely resected non-small-cell lung cancer, but there is no validated clinical or biologic predictor of the benefit of chemotherapy.

[ hide abstract ]

Discussed In Paper


Rx Annotations

No dosing information annotated.